The future of early-stage bioscience firms in the UK is in doubt and funding for start-ups has virtually ceased, says a report commissioned by the UK government.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.